Our observation of highly elevated GBP5 expression at the inflamed colonic mucosa in two geographically and culturally distinct IBD cohorts indicates that GBP5 plays a common and important role in the early steps of IBD pathogenesis and, therefore, is a potential therapeutic target for the management of IBD patients of various genetic and environmental backgrounds. Here, GBP5 is linked to inflammatory bowel disease.